Further tests such as in vitro tests for cytokine release in human whole blood and preclinical tests for CARPA and other in vitro tests should be further developed to identify patients at risk for severe IRRs or CARPA and for IgE-mediated anaphylaxis. The gene discussed is IGHE; the disease is anaphylaxis.